RxDoctor Payments DataLook up a doctor →

Charles Jobin, MD

Orthopaedic Surgery · New York, NYNPI 1770740342

Payments from drug & device makers

$541,028in general payments, 2019–2025

Across 495 payments — averaging $1092.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$304K
  • Zimmer Biomet$179K
  • Acumed LLC$44K
  • Medical Device Business Services, Inc.$10K
  • Synthes GmbH$2K
  • Integra Lifesciences Corporation$1K
  • plus $1K from 7 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$541,028 in reported general payments places this provider in the 90th percentile of 1,079 orthopaedic surgery providers in New York.

See all orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$453,522
Medicare patients
614
Services billed
4,128

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →